IL89662A - Pharmaceutical compositions comprising interferon-beta - Google Patents

Pharmaceutical compositions comprising interferon-beta

Info

Publication number
IL89662A
IL89662A IL89662A IL8966289A IL89662A IL 89662 A IL89662 A IL 89662A IL 89662 A IL89662 A IL 89662A IL 8966289 A IL8966289 A IL 8966289A IL 89662 A IL89662 A IL 89662A
Authority
IL
Israel
Prior art keywords
beta
pharmaceutical compositions
interferon
cml
preparation
Prior art date
Application number
IL89662A
Other languages
English (en)
Other versions
IL89662A0 (en
Inventor
Rita Michalevicz
Original Assignee
Interpharm Lab Ltd Kiryat Weiz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Interpharm Lab Ltd Kiryat Weiz filed Critical Interpharm Lab Ltd Kiryat Weiz
Priority to IL89662A priority Critical patent/IL89662A/xx
Publication of IL89662A0 publication Critical patent/IL89662A0/xx
Priority to CA002011992A priority patent/CA2011992C/en
Priority to DK90104936.1T priority patent/DK0388799T3/da
Priority to AT90104936T priority patent/ATE157544T1/de
Priority to DK94112221T priority patent/DK0643973T3/da
Priority to EP94112221A priority patent/EP0643973B1/de
Priority to ZA901994A priority patent/ZA901994B/xx
Priority to EP90104936A priority patent/EP0388799B1/de
Priority to ES94112221T priority patent/ES2198409T3/es
Priority to DE69034076T priority patent/DE69034076T2/de
Priority to DE69031355T priority patent/DE69031355T2/de
Priority to AT94112221T priority patent/ATE240116T1/de
Priority to ES90104936T priority patent/ES2107414T3/es
Priority to US07/495,027 priority patent/US5104653A/en
Priority to AU51445/90A priority patent/AU619960B2/en
Priority to JP2069519A priority patent/JP2883669B2/ja
Priority to GR970402418T priority patent/GR3024763T3/el
Publication of IL89662A publication Critical patent/IL89662A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
IL89662A 1989-03-19 1989-03-19 Pharmaceutical compositions comprising interferon-beta IL89662A (en)

Priority Applications (17)

Application Number Priority Date Filing Date Title
IL89662A IL89662A (en) 1989-03-19 1989-03-19 Pharmaceutical compositions comprising interferon-beta
CA002011992A CA2011992C (en) 1989-03-19 1990-03-12 Use of human interferon-beta for stimulation of erythropoiesis
ES90104936T ES2107414T3 (es) 1989-03-19 1990-03-15 Utilizacion de interferon-beta humano para la estimulacion de la eritropoyesis.
ES94112221T ES2198409T3 (es) 1989-03-19 1990-03-15 Utilizacion del interferon-beta humano para la preparacion de composiciones farmaceuticas para el tratamiento de la leucemia mieloide cronica.
DE69034076T DE69034076T2 (de) 1989-03-19 1990-03-15 Verwendung von Human-Beta-Interferon zur Herstellung von pharmazeutischen Zusammensetzungen zur Behandlung von chronischer Myeloidleukämie
DK94112221T DK0643973T3 (da) 1989-03-19 1990-03-15 Anvendelse af humant interferon-beta til fremstilling af farmaceutiske præparater til behandling af kronisk myeloid leukæmi
EP94112221A EP0643973B1 (de) 1989-03-19 1990-03-15 Verwendung von Human-Beta-Interferon zur Herstellung von pharmazeutischen Zusammensetzungen zur Behandlung von chronischer Myeloidleukämie
ZA901994A ZA901994B (en) 1989-03-19 1990-03-15 Use of human interferon-beta for stimulation of erythropoiesis
EP90104936A EP0388799B1 (de) 1989-03-19 1990-03-15 Verwendung von Human-Beta-Interferon zur Stimulierung der Erythropoiesis
DK90104936.1T DK0388799T3 (da) 1989-03-19 1990-03-15 Anvendelse af human beta-interferon til stimulering af erythropoiesis
AT90104936T ATE157544T1 (de) 1989-03-19 1990-03-15 Verwendung von human-beta-interferon zur stimulierung der erythropoiesis
DE69031355T DE69031355T2 (de) 1989-03-19 1990-03-15 Verwendung von Human-Beta-Interferon zur Stimulierung der Erythropoiesis
AT94112221T ATE240116T1 (de) 1989-03-19 1990-03-15 Verwendung von human-beta-interferon zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von chronischer myeloidleukämie
AU51445/90A AU619960B2 (en) 1989-03-19 1990-03-16 Use of human interferon-b for stimulation of erythropoiesis
US07/495,027 US5104653A (en) 1989-03-19 1990-03-16 Use of human interferon-beta for stimulation of erythropoiesis
JP2069519A JP2883669B2 (ja) 1989-03-19 1990-03-19 ヒトインターフエロン―βからなる医薬組成物
GR970402418T GR3024763T3 (en) 1989-03-19 1997-09-17 Use of human interferon-beta for stimulation of erythropoieses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL89662A IL89662A (en) 1989-03-19 1989-03-19 Pharmaceutical compositions comprising interferon-beta

Publications (2)

Publication Number Publication Date
IL89662A0 IL89662A0 (en) 1989-09-28
IL89662A true IL89662A (en) 1997-11-20

Family

ID=11059803

Family Applications (1)

Application Number Title Priority Date Filing Date
IL89662A IL89662A (en) 1989-03-19 1989-03-19 Pharmaceutical compositions comprising interferon-beta

Country Status (12)

Country Link
US (1) US5104653A (de)
EP (2) EP0643973B1 (de)
JP (1) JP2883669B2 (de)
AT (2) ATE157544T1 (de)
AU (1) AU619960B2 (de)
CA (1) CA2011992C (de)
DE (2) DE69034076T2 (de)
DK (2) DK0388799T3 (de)
ES (2) ES2198409T3 (de)
GR (1) GR3024763T3 (de)
IL (1) IL89662A (de)
ZA (1) ZA901994B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4128319A1 (de) * 1991-08-27 1993-03-04 Bioferon Biochem Substanz Neues rekombinantes human-ifn-beta, verfahren zu dessen herstellung und dieses enthaltende pharmazeutische zubereitungen
US5631219A (en) * 1994-03-08 1997-05-20 Somatogen, Inc. Method of stimulating hematopoiesis with hemoglobin
US6242417B1 (en) 1994-03-08 2001-06-05 Somatogen, Inc. Stabilized compositions containing hemoglobin
DE69636790T2 (de) * 1995-07-25 2007-10-11 Toray Industries, Inc. Interferon-beta gegen knochenerkrankungen
US6239109B1 (en) * 1998-02-09 2001-05-29 University Of Southern California Method of promoting erythropoiesis
JP4129178B2 (ja) * 2000-11-07 2008-08-06 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド 安定化されたインターフェロン組成物
EP1334177B1 (de) * 2000-11-14 2005-01-26 Université Libre de Bruxelles Herstellung und verwendung von dendritischen zellen
US7176278B2 (en) 2001-08-30 2007-02-13 Biorexis Technology, Inc. Modified transferrin fusion proteins
CA2521979A1 (en) * 2003-04-09 2004-10-28 University Of Utah Research Foundation Compositions and methods related to production of erythropoietin
US8906676B2 (en) 2004-02-02 2014-12-09 Ambrx, Inc. Modified human four helical bundle polypeptides and their uses
AU2005239995A1 (en) * 2004-03-31 2005-11-17 Nitromed, Inc. Methods for treating blood disorders with nitric oxide donor compounds
WO2007097951A2 (en) * 2006-02-17 2007-08-30 Nitromed, Inc. Methods using hydralazine compounds and isosorbide dinitrate or isosorbide mononitrate

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4460574A (en) * 1980-06-16 1984-07-17 Yabrov Alexander A Prophylaxis or treatment of interferon-sensitive diseases
GB8412564D0 (en) * 1984-05-17 1984-06-20 Searle & Co Structure and properties
CA1294215C (en) * 1986-10-27 1992-01-14 Ze'ev Shaked Pharmaceutical compositions of recombinant beta-interferon and formulation processes
US4851219A (en) * 1986-11-18 1989-07-25 Genentech, Inc. Method for the treatment of chronic myelogenous leukemia
AU2855189A (en) * 1988-01-25 1989-07-27 Baker Cummins Dermatologicals, Inc. Method of treating fibrotic disorders

Also Published As

Publication number Publication date
ES2198409T3 (es) 2004-02-01
DE69031355D1 (de) 1997-10-09
AU619960B2 (en) 1992-02-06
ZA901994B (en) 1990-12-28
DE69034076T2 (de) 2003-11-20
DK0388799T3 (da) 1998-03-30
GR3024763T3 (en) 1997-12-31
ES2107414T3 (es) 1997-12-01
CA2011992C (en) 2003-04-29
CA2011992A1 (en) 1990-09-19
AU5144590A (en) 1990-09-20
JPH0314523A (ja) 1991-01-23
ATE157544T1 (de) 1997-09-15
DE69031355T2 (de) 1998-01-08
US5104653A (en) 1992-04-14
EP0643973A1 (de) 1995-03-22
EP0643973B1 (de) 2003-05-14
JP2883669B2 (ja) 1999-04-19
IL89662A0 (en) 1989-09-28
EP0388799A3 (de) 1991-07-31
DK0643973T3 (da) 2003-09-08
DE69034076D1 (de) 2003-06-18
EP0388799A2 (de) 1990-09-26
ATE240116T1 (de) 2003-05-15
EP0388799B1 (de) 1997-09-03

Similar Documents

Publication Publication Date Title
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
GR3005528T3 (de)
PH27361A (en) N-acyl derivatives of the ll-333288 antitumor antibiotics and processes for their preparation
NZ216172A (en) Nucleosides and pharmaceutical compositions
GB8700398D0 (en) Compositions for surface treatment
IL89662A (en) Pharmaceutical compositions comprising interferon-beta
GR3035682T3 (en) Non-glycosylated fgf-4 and compositions containing the same.
FR2651435B1 (de)
NZ224363A (en) Ophthalmological compositions
BG49522A1 (en) Pharmaceutist composition accelarating the healing of mounds
EP0295559A3 (en) Pharmaceutical composition for the treatment of tumors
IL85189A (en) Beta-alkyl substituted melatonins,their preparation and pharmaceutical compositions containing them
IL90499A0 (en) Therapeutic uses of 2',5'-oligoadenylates
GB2204488B (en) Pharmaceutical compositions for the treatment or prophylaxis of skin disorders
IL87182A0 (en) Pharmaceutical compositions containing tumor necrosis factor for treating infections
EP0491873A4 (en) Therapeutic compositions; methods for treatment of hiv infections
AU1621888A (en) Pharmaceutical compositions for the treatment of cerebral psycho-organic syndromes
GR3018716T3 (en) 3'-deamino-4'-deoxy-4'-amino-8-fluoroanthracyclines and processes for their preparation
IL103856A0 (en) Aminoalkyl-substituted 5,6-dihydro-dibenz(b,e)azepin-6,11-dione-11-oximes,their preparation and pharmaceutical compositions containing them
IL94402A0 (en) Pharmaceutical compositions containing imidazodiazepines for the treatment of neurological symptoms
IL84550A (en) Pharmaceutical compositions for treatment of viral infections containing 3( -fluoro-3(-deoxy-thymidine
GB8819626D0 (en) Pharmaceutical composition for treatment of tumours
ZA906355B (en) Pharmaceutical compositions for the treatment of multiple sclerosis
IL82293A0 (en) Pharmaceutical compositions for the treatment of malaria
IL82295A (en) Compositions for treatment of the eyes

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed